Search engine for discovering works of Art, research articles, and books related to Art and Culture
ShareThis
Javascript must be enabled to continue!

Abstract 3504: Regulation of cell cycle progression by Ikaros in leukemia

View through CrossRef
Abstract Control of cell cycle progression is achieved by the coordinated function of a large set of genes that are highly conserved in eukaryotic organisms. Malignant cells have impaired regulation of cell cycle progression which results in uncontrolled cellular proliferation. Thus, understanding the regulation of cell cycle progression in malignant cells is essential to advance our knowledge of the process of malignant transformation and for designing novel treatments. Ikaros is a zinc finger protein that acts as a tumor suppressor in leukemia. The loss of Ikaros activity due to deletion or mutation has been associated with the development of high-risk B-cell acute lymphoblastic leukemia (B-ALL), as well as with T-cell ALL and acute myelogenous leukemia (AML). Ikaros binds DNA and regulates transcription of its target genes via chromatin remodeling. The mechanism of Ikaros tumor suppressor activity is largely unknown. Here, we present evidence that Ikaros regulates cell cycle progression in leukemia. Using quantitative Chromatin Immunoprecipitation assay (qChIP), we demonstrate that Ikaros binds in vivo to promoter regions of several genes that regulate cell cycle progression in B-ALL cell lines and in primary cells from patients with B-ALL. To study how Ikaros regulates transcription of these genes, luciferase reporter assays were performed. The promoter regions of three Ikaros target genes were cloned into luciferase reporter constructs. Each of these constructs has been co-transfected with Ikaros or an empty vector (as a negative control) into HEK 293T cells. Results showed that Ikaros represses transcription of the three genes that promote cell cycle progression. Overexpression of Ikaros in leukemia cells by retroviral transduction results in reduced transcription of the cell cycle promoting genes, as evidenced by quantitative real-time PCR (qRT-PCR), as well as cell cycle arrest. These data suggest that Ikaros regulates cell cycle progression in leukemia by direct repression of the transcription of the genes that promote cell cycle progression, and identifies one mechanism of Ikaros function as a tumor suppressor in leukemia. Citation Format: Elanora Dovat, Jonathon Payne, Carlos M. Casiano, Justin Sloane, Chandrika Gowda, Kimberly J. Payne, Sinisa Dovat, Chunhua Song. Regulation of cell cycle progression by Ikaros in leukemia. [abstract]. In: Proceedings of the 105th Annual Meeting of the American Association for Cancer Research; 2014 Apr 5-9; San Diego, CA. Philadelphia (PA): AACR; Cancer Res 2014;74(19 Suppl):Abstract nr 3504. doi:10.1158/1538-7445.AM2014-3504
Title: Abstract 3504: Regulation of cell cycle progression by Ikaros in leukemia
Description:
Abstract Control of cell cycle progression is achieved by the coordinated function of a large set of genes that are highly conserved in eukaryotic organisms.
Malignant cells have impaired regulation of cell cycle progression which results in uncontrolled cellular proliferation.
Thus, understanding the regulation of cell cycle progression in malignant cells is essential to advance our knowledge of the process of malignant transformation and for designing novel treatments.
Ikaros is a zinc finger protein that acts as a tumor suppressor in leukemia.
The loss of Ikaros activity due to deletion or mutation has been associated with the development of high-risk B-cell acute lymphoblastic leukemia (B-ALL), as well as with T-cell ALL and acute myelogenous leukemia (AML).
Ikaros binds DNA and regulates transcription of its target genes via chromatin remodeling.
The mechanism of Ikaros tumor suppressor activity is largely unknown.
Here, we present evidence that Ikaros regulates cell cycle progression in leukemia.
Using quantitative Chromatin Immunoprecipitation assay (qChIP), we demonstrate that Ikaros binds in vivo to promoter regions of several genes that regulate cell cycle progression in B-ALL cell lines and in primary cells from patients with B-ALL.
To study how Ikaros regulates transcription of these genes, luciferase reporter assays were performed.
The promoter regions of three Ikaros target genes were cloned into luciferase reporter constructs.
Each of these constructs has been co-transfected with Ikaros or an empty vector (as a negative control) into HEK 293T cells.
Results showed that Ikaros represses transcription of the three genes that promote cell cycle progression.
Overexpression of Ikaros in leukemia cells by retroviral transduction results in reduced transcription of the cell cycle promoting genes, as evidenced by quantitative real-time PCR (qRT-PCR), as well as cell cycle arrest.
These data suggest that Ikaros regulates cell cycle progression in leukemia by direct repression of the transcription of the genes that promote cell cycle progression, and identifies one mechanism of Ikaros function as a tumor suppressor in leukemia.
Citation Format: Elanora Dovat, Jonathon Payne, Carlos M.
Casiano, Justin Sloane, Chandrika Gowda, Kimberly J.
Payne, Sinisa Dovat, Chunhua Song.
Regulation of cell cycle progression by Ikaros in leukemia.
[abstract].
In: Proceedings of the 105th Annual Meeting of the American Association for Cancer Research; 2014 Apr 5-9; San Diego, CA.
Philadelphia (PA): AACR; Cancer Res 2014;74(19 Suppl):Abstract nr 3504.
doi:10.
1158/1538-7445.
AM2014-3504.

Related Results

Transcriptional Regulation of Cell Cycle Progression in T‐Cell Leukemia
Transcriptional Regulation of Cell Cycle Progression in T‐Cell Leukemia
The IKZF1 gene encodes the Ikaros protein that acts as a tumor suppressor in acute lymphoblastic leukemia (ALL). The role of Ikaros in T‐cell acute lymphoblastic leukemia (T‐ALL) h...
Epigenetic Regulation of Oncogenes in Leukemia by the Ikaros Tumor Suppressor
Epigenetic Regulation of Oncogenes in Leukemia by the Ikaros Tumor Suppressor
The IKZF1 gene controls expression of the Ikaros protein which functions as a tumor suppressor in pediatric acute lymphoblastic leukemia (ALL). Dysfunction of Ikaros due to deletio...
Regulation of the epigenetic signature in leukemia by Ikaros (800.5)
Regulation of the epigenetic signature in leukemia by Ikaros (800.5)
Ikaros encodes a DNA binding protein that regulates gene expression via chromatin remodeling and epigenetic mechanisms. The loss of Ikaros activity due to genetic or functional ina...
Use of qChIP to identify genes targeted by the Ikaros tumor suppressor
Use of qChIP to identify genes targeted by the Ikaros tumor suppressor
The IKAROS gene encodes a DNA binding zinc finger protein that is essential for hematopoietic differentiation and acts as a tumor suppressor in leukemia. The Ikaros protein is know...
Characterization of the DNA binding of Ikaros protein using three dimensional modeling and rapid prototyping technology
Characterization of the DNA binding of Ikaros protein using three dimensional modeling and rapid prototyping technology
Human hematopoiesis is controlled by the coordinated activity of various genes. The Ikaros gene encodes a DNA‐binding protein that is essential for normal hematopoiesis and acts as...
Are Cervical Ribs Indicators of Childhood Cancer? A Narrative Review
Are Cervical Ribs Indicators of Childhood Cancer? A Narrative Review
Abstract A cervical rib (CR), also known as a supernumerary or extra rib, is an additional rib that forms above the first rib, resulting from the overgrowth of the transverse proce...
Genomic potential of Streptomyces roseochromogenes NRRL 3504 for the production of specialized metabolites: analysis in silico
Genomic potential of Streptomyces roseochromogenes NRRL 3504 for the production of specialized metabolites: analysis in silico
Streptomyces roseochromogenes NRRL 3504 is the only known producer of aminocoumarin antibiotic clorobiocin – an inhibitor of bacterial DNA-gyrase and topoisomerase IV. Sequencing o...

Back to Top